Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Cancer subtyping has mainly relied on pathological and molecular means. Massively parallel sequencing-enabled subtyping requires genomic markers to be developed based on global features rather than individual mutations for effective implementation. | Genomic subtyping of liver cancers with prognostic application